Viking Therapeutics Inc (NASDAQ:VKTX) shares, rose in value, with the stock price up by 1.41% to the previous day’s close as strong demand from buyers drove the stock to $78.44.
Actively observing the price movement in the last trading, the stock closed the session at $77.35. The value of beta (5-year monthly) was 1.06. Referring to stock’s 52-week performance, its high was $99.41, and the low was $8.28. On the whole, VKTX has fluctuated by -14.12% over the past month.
With the market capitalization of Viking Therapeutics Inc currently standing at about $8.58 billion, investors are eagerly awaiting this quarter’s results, scheduled for Apr 24, 2024 – Apr 29, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.28, which is expected to increase to -$0.19 for fiscal year -$1.12 and then to about -$1.51 by fiscal year 2025. Data indicates that the EPS growth is expected to be -23.10% in 2025, while the next year’s EPS growth is forecast to be -34.80%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that VKTX’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of VKTX currently trading nearly 6.95% and 50.38% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 59.64, while the 7-day volatility ratio is showing 6.56% which for the 30-day chart, stands at 9.36%. Furthermore, Viking Therapeutics Inc (VKTX)’s beta value is 1.12, and its average true range (ATR) is 7.21.
A comparison of Viking Therapeutics Inc (VKTX) with its peers suggests the former has fared considerably weaker in the market. VKTX showed an intraday change of 1.41% in last session, and over the past year, it grew by 371.11%%.
Data on historical trading for Viking Therapeutics Inc (NASDAQ:VKTX) indicates that the trading volumes over the past 10 days have averaged 5.38 million and over the past 3 months, they’ve averaged 6.55 million. According to company’s latest data on outstanding shares, there are 100.11 million shares outstanding.
Nearly 8.91% of Viking Therapeutics Inc’s shares belong to company insiders and institutional investors own 69.34% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.14 million shares as on Mar 15, 2024, resulting in a short ratio of 0.93. According to the data, the short interest in Viking Therapeutics Inc (VKTX) stood at 10.32% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 12.02 million. The stock has risen by 321.49% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VKTX stock heading into the next quarter.
